tirzepatide-containing products TIRZEPATIDE – Research Peptide Sejaro® (tirzepatide)

And I know as a doctor, it always gives me pause of like what conditions could we potentially be missing

Prior to exclusion of these data, the ratio of the area under a curve (AUC) of the therapeutic agent concentration in systemic circulation versus time that was achieved when the drug was administered by the ID route (AUC ID (ng.hr/mL SEM)) was 3890.00 94.73

These may be caused by shaving or use of antiperspirants (not deodorants)

It helps balance how well the drug works and its safety

While these results are promising, the sample sizes are very small, and further studies are warranted to support these findings

Dulaglutide (Trulicity), another once-weekly GLP-1 agonist, reports injection site reaction rates of approximately 0.7% in its FDA label